Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
Review
[키워드] 2019 novel coronavirus
ACE inhibitor
ACE2
ACE2 expression
angiotensin receptor blocker
Antihypertensive drug
antihypertensive drugs
blockade
cell membrane
COVID-19
COVID-19 infection
cytoplasm
death
enzyme
Evidence
exacerbated
facilitate
homeostasis
hypertension
Infection
maintain
mechanism
nervous system
pandemic
Protein
RAS
RAS inhibitor
respiratory
Safe
SARS
SARS-CoV-2
Sepsis
shown
sodium balance
subject
subjects
therapy
viral entry
viral surface
virus
[DOI] 10.1186/s40885-020-00144-0 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s40885-020-00144-0 PMC 바로가기 [Article Type] Review